Titan Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 14, 2022 at 04:31 pm EST
Titan Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was USD 0.095 million compared to USD 0.264 million a year ago. Net loss was USD 2.64 million compared to USD 1.92 million a year ago. Basic loss per share from continuing operations was USD 0.18 compared to USD 0.19 a year ago.
For the nine months, revenue was USD 0.436 million compared to USD 1.39 million a year ago. Net loss was USD 7.64 million compared to USD 6.24 million a year ago. Basic loss per share from continuing operations was USD 0.59 compared to USD 0.64 a year ago.